NFATc4 Promotes Lung Adenocarcinoma Progression via the CCNB1/CDK1 Pathway and Is a Potential Prognostic Biomarker.

Cancer Sci · 2025 · PMC12400067 · PMID 40639671

Europe PMC DOI

hedged sentence

0.4665

closest p · 9.3× alpha

0.4665

boldest claim

The sentences

did not reach statistical significancep = 0.4665not close (p > 0.1)

The difference, however, did not reach statistical significance in individuals who present with LNM ( p = 0.4665) (Figure S2A–C ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.